Liontrust Investment Partners LLP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Liontrust Investment Partners LLP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,075,280
-16.7%
421,000
-5.7%
0.06%
-18.1%
Q1 2023$4,893,640
+153.7%
446,5000.0%0.07%
+111.8%
Q4 2022$1,928,880
-99.9%
446,5000.0%0.03%
-37.0%
Q3 2022$3,357,680,000
-25.2%
446,5000.0%0.05%
-14.3%
Q2 2022$4,487,325,000
-18.8%
446,5000.0%0.06%
-12.5%
Q1 2022$5,527,670,000
-45.9%
446,5000.0%0.07%
-40.5%
Q4 2021$10,211,455,000446,5000.12%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders